Enhancing Participation of Chronic Stroke Patients by Constraint Induced Movement Therapy (HOMECIMT)
HOMECIMT
1 other identifier
interventional
156
1 country
1
Brief Summary
The aim of this study is to evaluate the efficacy of a modified approach of constraint induced movement therapy ("CIMT at home") for chronic stroke patients, compared to conventional physiotherapy and occupational therapy ("therapy as usual) with regard to the ability to participate in everyday activities.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable stroke
Started Oct 2011
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 26, 2011
CompletedFirst Posted
Study publicly available on registry
April 28, 2011
CompletedStudy Start
First participant enrolled
October 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2013
CompletedDecember 16, 2014
December 1, 2014
1.7 years
April 26, 2011
December 14, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Motor Activity Log - Quality Of Movement (MAL-QOM) and Wolf Motor Function Test - Performance Time (WMFT-PT)
"Participation" defined as equal involvement in all aspects of society and daily living for people with disabilities is a composite outcome of the following two measures: The MAL-QOM is a self-administered measure of how well 30 daily activities are performed to assess the change in the quality of arm and hand use and the WMFT-PT, measured as the average time (in seconds) to complete 15 tasks, to evaluate the change in arm and hand function.
4 weeks (post-treatment) relative to baseline performance
Secondary Outcomes (6)
Motor Activity Log - Quality Of Movement (MAL-QOM) and MAL- Amount Of Use (MAL-AOU)
3 and 6 months relative to baseline performance
Wolf Motor Function Test - Performance Time (WMFT-PT) and WMFT Functional Ability (WMFT-FA)
6 months relative to baseline performance
Nine-Hole Peg-Test
4 weeks (post-treatment) and 6 months relative to baseline performance
Stroke-Impact-Scale (SIS)
4 weeks (post-treatment) and 6 months relative to baseline performance
Barthel Index(BI)
4 weeks (post-treatment) and 6 months relative to baseline performance
- +1 more secondary outcomes
Study Arms (2)
mod. Constraint-Induced Movement Therapy
EXPERIMENTALCIMT at home is applied in the patients' home over the course of four weeks including (i.e. 20 consecutive days) 2 hours of daily training together with an instructed non-professional coach (e.g. family member) applying shaping techniques.
Therapy as usual
OTHERPatients in this arm will receive usual care dose-matched to the intervention group (250-300 minutes).
Interventions
Therapists of the intervention group are trained in "CIMT at home". During an initial home visit the therapist determines together with the patient an individually tailored home training program focussing on everyday practice and instructs the non-professional coach. For four weeks the patients will perform 2 hours of daily training at home together with an instructed non-professional coach (e.g. family member) applying shaping techniques (i.e. 20 consecutive days). Patients are supposed to wear a resting hand splint for the entire treatment period for 4 to 6 hours daily. During the four weeks the therapist will provide 5 weekly visits at the patients' home to instruct and supervise the training.
Therapy as usual consists of the therapy, which is usually provided by the occupational or physical therapist. Therapy will be applied at the patients home or at the therapists' practice.
Eligibility Criteria
You may qualify if:
- age ≥ 18 years
- Stroke onset \> 6 months prior to study enrollment
- upper extremity hemiparesis with impairment of hand and/or arm
- minimal function of the hand (at least 10º active wrist extension, at least 10º active of thumb abduction/extension, and at least 10º of extension two additional fingers)
- non-professional coach (e.g. family member)
- prescription of physical or occupational therapy
You may not qualify if:
- lack of knowledge of German
- serious impairment of verbal communication ability (e.g. severe aphasia)
- inability to consent (e.g. dementia)
- severe neuro-cognitive deficits (MMSE \<23)
- terminal illness, life-threatening co-morbidity
- simultaneous participation in another treatment study targeting stroke recovery
- subjects may not have already received constraint induced movement therapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Primary Medical Care, University Medical Center Hamburg-Eppendorf
Hamburg, 20246, Germany
Related Publications (2)
Barzel A, Ketels G, Stark A, Tetzlaff B, Daubmann A, Wegscheider K, van den Bussche H, Scherer M. Home-based constraint-induced movement therapy for patients with upper limb dysfunction after stroke (HOMECIMT): a cluster-randomised, controlled trial. Lancet Neurol. 2015 Sep;14(9):893-902. doi: 10.1016/S1474-4422(15)00147-7. Epub 2015 Jul 28.
PMID: 26231624DERIVEDBarzel A, Ketels G, Tetzlaff B, Kruger H, Haevernick K, Daubmann A, Wegscheider K, Scherer M. Enhancing activities of daily living of chronic stroke patients in primary health care by modified constraint-induced movement therapy (HOMECIMT): study protocol for a cluster randomized controlled trial. Trials. 2013 Oct 14;14:334. doi: 10.1186/1745-6215-14-334.
PMID: 24124993DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anne Barzel, MD
Department of Primary Medical Care, University Medical Center Hamburg-Eppendorf
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 26, 2011
First Posted
April 28, 2011
Study Start
October 1, 2011
Primary Completion
June 1, 2013
Study Completion
June 1, 2013
Last Updated
December 16, 2014
Record last verified: 2014-12